IBDEI0GS ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21259,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,21259,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,21259,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,21260,0)
 ;;=E10.21^^58^832^8
 ;;^UTILITY(U,$J,358.3,21260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21260,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,21260,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,21260,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,21261,0)
 ;;=E10.9^^58^832^12
 ;;^UTILITY(U,$J,358.3,21261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21261,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,21261,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,21261,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,21262,0)
 ;;=E11.21^^58^832^17
 ;;^UTILITY(U,$J,358.3,21262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21262,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,21262,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,21262,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,21263,0)
 ;;=E11.39^^58^832^18
 ;;^UTILITY(U,$J,358.3,21263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21263,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,21263,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,21263,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,21264,0)
 ;;=E11.43^^58^832^15
 ;;^UTILITY(U,$J,358.3,21264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21264,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,21264,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,21264,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,21265,0)
 ;;=E11.59^^58^832^13
 ;;^UTILITY(U,$J,358.3,21265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21265,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,21265,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,21265,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,21266,0)
 ;;=E11.618^^58^832^14
 ;;^UTILITY(U,$J,358.3,21266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21266,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,21266,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,21266,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,21267,0)
 ;;=E11.621^^58^832^16
 ;;^UTILITY(U,$J,358.3,21267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21267,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,21267,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,21267,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,21268,0)
 ;;=E11.622^^58^832^20
 ;;^UTILITY(U,$J,358.3,21268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21268,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,21268,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,21268,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,21269,0)
 ;;=E11.65^^58^832^19
 ;;^UTILITY(U,$J,358.3,21269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21269,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,21269,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,21269,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,21270,0)
 ;;=E11.9^^58^832^21
 ;;^UTILITY(U,$J,358.3,21270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21270,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,21270,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,21270,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,21271,0)
 ;;=E13.9^^58^832^22
 ;;^UTILITY(U,$J,358.3,21271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21271,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,21271,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,21271,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,21272,0)
 ;;=E16.2^^58^832^29
 ;;^UTILITY(U,$J,358.3,21272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21272,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,21272,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,21272,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,21273,0)
 ;;=E20.0^^58^832^34
 ;;^UTILITY(U,$J,358.3,21273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21273,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,21273,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,21273,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,21274,0)
 ;;=E20.9^^58^832^30
 ;;^UTILITY(U,$J,358.3,21274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21274,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,21274,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,21274,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,21275,0)
 ;;=E23.0^^58^832^31
 ;;^UTILITY(U,$J,358.3,21275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21275,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,21275,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,21275,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,21276,0)
 ;;=E27.1^^58^832^51
 ;;^UTILITY(U,$J,358.3,21276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21276,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,21276,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,21276,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,21277,0)
 ;;=E27.2^^58^832^1
 ;;^UTILITY(U,$J,358.3,21277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21277,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,21277,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,21277,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,21278,0)
 ;;=E27.3^^58^832^23
 ;;^UTILITY(U,$J,358.3,21278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21278,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,21278,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,21278,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,21279,0)
 ;;=E29.1^^58^832^52
 ;;^UTILITY(U,$J,358.3,21279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21279,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,21279,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,21279,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,21280,0)
 ;;=E55.9^^58^832^59
 ;;^UTILITY(U,$J,358.3,21280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21280,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,21280,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,21280,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,21281,0)
 ;;=E66.01^^58^832^38
 ;;^UTILITY(U,$J,358.3,21281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21281,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,21281,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,21281,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,21282,0)
 ;;=E66.8^^58^832^42
 ;;^UTILITY(U,$J,358.3,21282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21282,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,21282,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,21282,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,21283,0)
 ;;=E66.9^^58^832^43
 ;;^UTILITY(U,$J,358.3,21283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21283,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,21283,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,21283,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,21284,0)
 ;;=E74.39^^58^832^35
 ;;^UTILITY(U,$J,358.3,21284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21284,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,21284,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,21284,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,21285,0)
 ;;=E83.30^^58^832^46
 ;;^UTILITY(U,$J,358.3,21285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21285,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,21285,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,21285,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,21286,0)
 ;;=E83.51^^58^832^28
 ;;^UTILITY(U,$J,358.3,21286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21286,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,21286,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,21286,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,21287,0)
 ;;=E83.52^^58^832^26
 ;;^UTILITY(U,$J,358.3,21287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21287,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,21287,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,21287,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,21288,0)
 ;;=E87.5^^58^832^27
 ;;^UTILITY(U,$J,358.3,21288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21288,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,21288,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,21288,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,21289,0)
 ;;=E89.2^^58^832^48
 ;;^UTILITY(U,$J,358.3,21289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21289,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,21289,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,21289,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,21290,0)
 ;;=E89.6^^58^832^47
 ;;^UTILITY(U,$J,358.3,21290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21290,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,21290,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,21290,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,21291,0)
 ;;=L68.0^^58^832^25
 ;;^UTILITY(U,$J,358.3,21291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21291,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,21291,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,21291,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,21292,0)
 ;;=M80.00XA^^58^832^2
 ;;^UTILITY(U,$J,358.3,21292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21292,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,21292,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,21292,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,21293,0)
 ;;=M81.0^^58^832^3
 ;;^UTILITY(U,$J,358.3,21293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21293,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,21293,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,21293,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,21294,0)
 ;;=M85.80^^58^832^44
 ;;^UTILITY(U,$J,358.3,21294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21294,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,21294,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,21294,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,21295,0)
 ;;=N62.^^58^832^24
 ;;^UTILITY(U,$J,358.3,21295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21295,1,3,0)
 ;;=3^Gynecomastia
